BioCentury
ARTICLE | Finance

OSI leverages foundational deal with Oxford to build its life sciences portfolio

OSI parlays University of Oxford deal into $800M evergreen fund, expanding portfolio

August 14, 2020 9:34 PM UTC

A long-term agreement with the University of Oxford has provided a strong foundation on which investment firm Oxford Sciences Innovation has been able to build its fund-raising and broaden its portfolio into new disease areas and modalities.

Despite Oxford’s more than 800-year history, its arrangement with Oxford Sciences Innovation (OSI) may be its first successful attempt at systematically driving the translation and commercialization of its IP through company creation...